首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1547295

全球融合活检市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Fusion Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2032 年，全球融合活检市场的市场规模将从 2023 年的 6.5256 亿美元达到近 14.4681 亿美元，2024-2032 年研究期间复合年增长率为 9.25%。

融合活检用于在活检手术期间获得前列腺的详细 3D 影像。这种方法提高了异常组织区域的可见度，以便将活检针引入其中。之后，可以采集组织样本并在显微镜下检查癌症迹象。其他类型的活检可能会漏掉前列腺癌细胞，但融合活检可能有助于定位它们。它可以帮助早期发现癌症和製定治疗计划。 MRI 超音波融合导引活检是该手术的另一个名称。复杂的磁振造影 (MRI) 扫描与超音波影像相结合，使泌尿科医生能够精确定位必须进行准确活检的前列腺区域。医生可以使用这种方法对怀疑患有癌症的前列腺的特定大小进行采样。融合切片检查依切片途径可分为两大类：经会阴切片检查和经直肠切片检查。融合活检的最终用户包括医院、诊断机构和门诊护理诊所。

市场动态

与其他传统手术如 TRUS 活检、PSA 测试或直肠指检等相比，标靶 MR/超音波融合活检在定义前列腺病变方面具有高灵敏度和特异性，预计将促进市场扩张。融合活检系统在诊断侵袭性癌症方面的可靠性和可重复性预计将使其成为前列腺活检的标准工具。由于越来越多的放射科医生获得了阅读前列腺 MRI 的经验以及 PI-RADS 和 Gleason 评分等标准影像分级方法的部署，因此针对 MR/超音波融合活检设备的使用已经扩大。各国政府组织对改善医疗基础设施的日益关注将成为融合活检市场利润丰厚的成长动力。此外，对融合活检领域的投资增加将提供巨大的成长潜力。由于世界各地对定期临床检查和可接受的报销政策的认识不断提高，融合活检市场可能会出现有希望的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球融合活检市场的每个细分市场进行了包容性评估。融合活检行业的成长和趋势为这项研究提供了整体方法。

市场区隔

融合活检市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按路线

经直肠
经会阴

按最终用途

医院
诊断中心
门诊护理中心

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲融合活检市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。融合切片市场的主要参与者包括 Eigen Health、Koninklijke Philips NV、Hitachi Ltd.、MedCom、ESAOTE SpA、。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：融合切片公司的竞争格局

融合切片市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Eigen Health

公司概况
公司收入
产品
最新动态

Koninklijke Philips NV

公司概况
公司收入
产品
最新动态

Hitachi Ltd.

公司概况
公司收入
产品
最新动态

MedCom

公司概况
公司收入
产品
最新动态

ESAOTE SpA

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11216669

The global demand for Fusion Biopsy Market is presumed to reach the market size of nearly USD 1446.81 Million by 2032 from USD 652.56 Million in 2023 with a CAGR of 9.25% under the study period 2024-2032.

A Fusion Biopsy is used to obtain a detailed 3-D image of the prostate during a biopsy surgery. This method improves the visibility of an aberrant tissue area to lead the biopsy needle into it. After that, a sample of tissue can be taken and examined under a microscope for cancer indications. Other types of biopsies may miss prostate cancer cells, but a fusion biopsy may help locate them. It could aid in the early detection of cancer and treatment planning. MRI ultrasound fusion-guided biopsy is another name for this procedure. A sophisticated magnetic resonance imaging (MRI) scan is combined with an ultrasound image to enable urologists to pinpoint the prostate area that must be biopsied accurately. Doctors can use this method to sample the specific size of the prostate where cancer is suspected. The fusion biopsy can be divided into two categories based on the biopsy route: transperineal and transrectal. End-users of fusion biopsy include hospitals, diagnostic facilities, and ambulatory care clinics.

MARKET DYNAMICS

The high sensitivity and specificity of targeted MR/Ultrasound fusion biopsy in defining prostate lesions compared to other traditional procedures like TRUS biopsy, PSA test, or Digital Rectal Examination is expected to promote market expansion. The fusion biopsy system's reliability and reproducibility in diagnosing aggressive cancers are projected to make it a standard tool in prostate biopsy. The use of targeted MR/Ultrasound fusion biopsy devices has expanded due to an increasing number of radiologists obtaining experience in reading prostate MRI and the deployment of standard image grading methods such as PI-RADS and Gleason score. The increasing focus of government organizations in various countries on improving healthcare infrastructure will be a lucrative growth driver for the fusion biopsy market. Additionally, increased investment in the fusion biopsy sector will provide significant growth potential. The fusion biopsy market will likely see promising growth due to increased awareness about regular clinical examinations and acceptable reimbursement policies in various regions worldwide.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fusion Biopsy. The growth and trends of Fusion Biopsy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fusion Biopsy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Route

Transrectal
Transperineal

By End-use

Hospitals
Diagnostic Centers
Ambulatory Care Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fusion Biopsy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fusion Biopsy market include Eigen Health, Koninklijke Philips N.V., Hitachi Ltd., MedCom, ESAOTE SpA, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. FUSION BIOPSY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Route
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY ROUTE

5.1. Overview By Route
5.2. Historical and Forecast Data Analysis By Route
5.3. Transrectal Historic and Forecast Sales By Regions
5.4. Transperineal Historic and Forecast Sales By Regions

6. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data Analysis By End-use
6.3. Hospitals Historic and Forecast Sales By Regions
6.4. Diagnostic Centers Historic and Forecast Sales By Regions
6.5. Ambulatory Care Centers Historic and Forecast Sales By Regions

7. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE FUSION BIOPSY COMPANIES

8.1. Fusion Biopsy Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF FUSION BIOPSY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Eigen Health
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Koninklijke Philips N.V.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Hitachi Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. MedCom
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. ESAOTE SpA
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments